Wellnex Life Limited
WNX · AIM · Retail · mcap £4.0m · 5.5p
Financials · LTM to 30 Jun 26
Source: results 01 Sep 26 ↗
Going-concern uncertaintyQualified audit
- Revenue
- £12.6m
- Operating profit
- –
- Net income
- −£2.3m
- Free cash flow
- −£1.3m
- Net debt
- £4.6m
- Market cap
- £4.0m
- EV / EBIT
- –
- FCF yield
- −32.3%
- Price / book
- 1.0×
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Every line as the company printed it, newest first – each period in the latest version the company published (restated figures where a later report restated them), in its own currency and units. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.
Standardised line items in £m, comparable across companies; when a later report restates a period, the later figure is shown. Italic = calculated (LTM, H2 = FY − H1). Hover a value for its source.
Latest report: FY Jun 26 (twelve months to 30 Jun 26), published 01 Sep 26 · read the results ↗
| FY Jun 26 source | |
|---|---|
| Parent | |
| Loss after income tax | (15,604) |
| Total comprehensive loss | (15,604) |
| Statement of financial position | |
| Parent | |
| 30 June 2026 30 June 2025 | |
| $'000 $'000 | |
| Total current assets | 8,390 |
| Total assets | 28,124 |
| Total current liabilities | 16,765 |
| Total liabilities | 16,877 |
| Equity | |
| Issued capital | 151,447 |
| Share based payment reserve | 776 |
| Accumulated losses | (140,976) |
| Total equity | 11,247 |
| Contingent liabilities | |
| Refer to note 16 (2025: nil) | |
| Capital commitments - Property, plant and equipment | |
| Material accounting policy information | |
| Note 19. Interests in controlled entities | |
| Parent | |
| Principal place of business / Ownership interest Ownership interest | |
| Country of 30 June 2026 30 June 2025 | |
| Name incorporation Principal activities % % | |
| Wattle Health Australia Investments Pty Ltd (c) Australia Investment | 100.00% |
| BSPS Aust Pty Ltd Australia Brand Solutions Australia and Pharma Solutions Australia businesses | 100.00% |
| BSPSPA Pty Ltd Australia Holds the IP and trademarks of Pain Away | 100.00% |
| 1LH Pty Ltd (a), (c) Australia Medical Cannabis | 50.00% |
| Cann Comm Pty Ltd (a), (b), (c) Australia Technology - Tele Health | 50.00% |
| Wellnex Life UK Ltd (a), (b) United Kingdom Sales and Distribution UK | 100.00% |
| (b) Incorporated by the Company during the previous financial year. | |
| (c) Deregistered during 2026 financial year. | |
| Note 20. Events after the reporting period | |
| Consolidated | |
| 30 June 2026 30 June 2025 | |
| $'000 $'000 | |
| Loss after income tax expense for the year | (15,604) |
| Adjustments for | |
| Depreciation and amortisation | 1,379 |
| Share-based payments | 4,189 |
| Impairment of Pain Away brand asset | - |
| Impairment of inventory | 1,482 |
| Finance extension costs capitalised | - |
| Change in operating assets and liabilities | |
| Decrease/(increase) in trade and other receivables | 1,789 |
| Decrease/(increase) in inventories | (1,028) |
| Decrease in prepayments | 76 |
| Increase/(decrease) in trade and other payables | 5,931 |
| Decrease in employee benefits | (170) |
| Net cash used in operating activities | (1,956) |
| Note 22. Loss per share | |
| Consolidated | |
| 30 June 2026 30 June 2025 | |
| $'000 $'000 | |
| Loss after income tax attributable to the owners of Wellnex Life Limited | (15,604) |
| Number Number | |
| Weighted average number of ordinary shares used in calculating basic earnings per share | 29,260,693 |
| Weighted average number of ordinary shares used in calculating diluted earnings per share | 29,260,693 |
| Cents Cents | |
| Basic loss per share | (53.33) |
| Diluted loss per share | (53.33) |
| Wellnex Life Limited Consolidated entity disclosure statement As at 30 June 2026 | |
| Place formed / Ownership interest | |
| Entity name Entity type Country of incorporation % Tax residency | |
| Wellnex Life Limited Body corporate Australia Australia | - |
| BSPS Aust Pty Ltd Body corporate Australia Australia | 100.00% |
| BSPSPA Pty Ltd Body corporate Australia Australia | 100.00% |
| Wellnex Life UK Ltd Body corporate United Kingdom United Kingdom | 100.00% |
| 30 Jun 26 source | |
|---|---|
| Parent | |
| Total current assets | 8,390 |
| Total assets | 28,124 |
| Total current liabilities | 16,765 |
| Total liabilities | 16,877 |
| Equity | |
| Issued capital | 151,447 |
| Share based payment reserve | 776 |
| Accumulated losses | (140,976) |
| Total equity | 11,247 |
| Contingent liabilities | |
| Refer to note 16 (2025: nil) | |
| Capital commitments - Property, plant and equipment | |
| Material accounting policy information | |
| Note 19. Interests in controlled entities | |
| Parent | |
| Principal place of business / Ownership interest Ownership interest | |
| Country of 30 June 2026 30 June 2025 | |
| Name incorporation Principal activities % % | |
| Wattle Health Australia Investments Pty Ltd (c) Australia Investment | 100.00% |
| BSPS Aust Pty Ltd Australia Brand Solutions Australia and Pharma Solutions Australia businesses | 100.00% |
| BSPSPA Pty Ltd Australia Holds the IP and trademarks of Pain Away | 100.00% |
| 1LH Pty Ltd (a), (c) Australia Medical Cannabis | 50.00% |
| Cann Comm Pty Ltd (a), (b), (c) Australia Technology - Tele Health | 50.00% |
| Wellnex Life UK Ltd (a), (b) United Kingdom Sales and Distribution UK | 100.00% |
| (b) Incorporated by the Company during the previous financial year. | |
| (c) Deregistered during 2026 financial year. | |
| Note 20. Events after the reporting period | |
| Consolidated | |
| 30 June 2026 30 June 2025 | |
| $'000 $'000 | |
| Loss after income tax expense for the year | (15,604) |
| Adjustments for | |
| Depreciation and amortisation | 1,379 |
| Share-based payments | 4,189 |
| Impairment of Pain Away brand asset | - |
| Impairment of inventory | 1,482 |
| Finance extension costs capitalised | - |
| Change in operating assets and liabilities | |
| Decrease/(increase) in trade and other receivables | 1,789 |
| Decrease/(increase) in inventories | (1,028) |
| Decrease in prepayments | 76 |
| Increase/(decrease) in trade and other payables | 5,931 |
| Decrease in employee benefits | (170) |
| Net cash used in operating activities | (1,956) |
| Note 22. Loss per share | |
| Consolidated | |
| 30 June 2026 30 June 2025 | |
| $'000 $'000 | |
| Loss after income tax attributable to the owners of Wellnex Life Limited | (15,604) |
| Number Number | |
| Weighted average number of ordinary shares used in calculating basic earnings per share | 29,260,693 |
| Weighted average number of ordinary shares used in calculating diluted earnings per share | 29,260,693 |
| Cents Cents | |
| Basic loss per share | (53.33) |
| Diluted loss per share | (53.33) |
| Wellnex Life Limited Consolidated entity disclosure statement As at 30 June 2026 | |
| Place formed / Ownership interest | |
| Entity name Entity type Country of incorporation % Tax residency | |
| Wellnex Life Limited Body corporate Australia Australia | - |
| BSPS Aust Pty Ltd Body corporate Australia Australia | 100.00% |
| BSPSPA Pty Ltd Body corporate Australia Australia | 100.00% |
| Wellnex Life UK Ltd Body corporate United Kingdom United Kingdom | 100.00% |
| FY Jun 26 source | |
|---|---|
| Directors | |
| Ash Vesali (Non-Executive Director) | |
| Jeffrey Yeh (Non-Executive Director) | |
| Hilton Wood (Non-Executive Director) | |
| Company secretary | |
| Registered office Building 2, Level | 3, |
| and Principal place of business Suite 72, 574 Plummer St | |
| Port Melbourne VIC | 3207 |
| Share register Computershare Investor Registry Services | |
| Yarra Falls | |
| 452 Johnston Street | |
| Abbotsford, Victoria, | 3067 |
| Auditor William Buck | |
| Level 20, 181 William Street | |
| Melbourne VIC | 3000 |
| Website https://www.wellnexlife.com.au | |
| Wellnex Life Limited | |
| Directors' report | |
| Directors | |
| Eric Jiang (Interim Executive Chair) Non-Executive Director; appointed Interim Executive Chair on 10 March 2026 | - |
| Jeffrey Yeh (Non-Executive Director) | |
| George Karafotias (Executive Director and joint Chief Executive Officer/Managing Director) resigned 14 August 2025 | - |
| Andrew Vidler (Non-Executive Director) resigned 15 September 2025 | - |
| Zack Bozinovski (Executive Director and joint Chief Executive Officer/Managing Director) resigned 21 October 2025 | - |
| Vivienne Zhang (Executive Director) resigned 26 November 2025 | - |
| Ruari McGirr (Non-Executive Director) resigned 27 November 2025 | - |
| Hilton Wood (Non-Executive Director) appointed 12 June 2026 | - |
| 30 Jun 26 | 30 Jun 25 | |
|---|---|---|
| Non-current assets | ||
| Property, plant & equipment | 0.0 | 0.0 |
| Non-current assets | 0.0 | 9.4 |
| Current assets | ||
| Inventories | 0.2 | 1.9 |
| Trade receivables | 1.3 | 1.2 |
| Cash | 0.4 | 0.2 |
| Current assets | 12.3 | 4.0 |
| Total assets | 12.3 | 13.4 |
| Current liabilities | ||
| Trade payables | 3.2 | 4.9 |
| Borrowings, current | 5.1 | 2.7 |
| Current liabilities | 8.5 | 8.0 |
| Non-current liabilities | ||
| Non-current liabilities | 0.0 | 0.1 |
| Total liabilities | 8.5 | 8.0 |
| Equity | ||
| Total equity | 3.9 | 5.4 |
Read automatically from each results announcement. Check the source before relying on a figure.
Company filings. Not investment advice.